Literature DB >> 34125361

Oocyte stimulation parameters influence the number and proportion of mature oocytes retrieved in assisted reproductive technology cycles.

Damla C Gonullu1, David H McCulloh2, LeRoy G Robinson3, Cheongeun Oh4, David L Keefe5,3.   

Abstract

PURPOSE: Whether differences in stimulation parameters alter the number and proportion of MII oocytes retrieved.
METHODS: Records of 2546 patients were examined, looking at age, day 2/3 follicle-stimulating hormone (FSH) and estradiol (E2) levels, total dose of gonadotropins administered (including FSH and human menopausal gonadotropin [hMG]), fraction of hMG administered, number of days of treatment with gonadotropins, and the dose of gonadotropins administered per day. We segregated the patients into 3 different classes depending on the trigger method used and 2 groups based on egg freeze vs. ICSI. Multiple regression methods were used to examine associations between stimulation parameters and the total number of eggs, number of immature oocytes (Poisson regression), and the fraction of retrieved oocytes that were immature (Logistic regression).
RESULTS: After adjustments for different triggers and egg freeze versus ICSI, both the #immature oocytes and the immature fraction of oocytes were associated with the total gonadotropin dose (inversely) and the gonadotropin dose/day (positively). Other parameters were associated with the number of immature oocytes but were also associated with the number of oocytes retrieved.
CONCLUSIONS: Stimulations using less total gonadotropin and more gonadotropin per day were associated with more immaturity. The type of trigger method used for final maturation was associated with immaturity but was believed to be predominantly due to trigger assignment to patients based on response. The association between use of ICSI and less immaturity was believed to be due to additional time for maturation in the ICSI group.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Assisted reproductive technology; Oocyte maturation; Oocyte stimulation; Ovulation trigger

Mesh:

Substances:

Year:  2021        PMID: 34125361      PMCID: PMC8490597          DOI: 10.1007/s10815-021-02220-2

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  10 in total

Review 1.  Mild ovarian stimulation.

Authors:  Jerome H Check
Journal:  J Assist Reprod Genet       Date:  2007-12-04       Impact factor: 3.412

2.  Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.

Authors:  Anders Nyboe Andersen; Paul Devroey; Joan-Carles Arce
Journal:  Hum Reprod       Date:  2006-07-27       Impact factor: 6.918

Review 3.  In vitro maturation: a committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2020-12-24       Impact factor: 7.329

Review 4.  Failure to launch: aberrant cumulus gene expression during oocyte in vitro maturation.

Authors:  Hannah M Brown; Kylie R Dunning; Melanie Sutton-McDowall; Robert B Gilchrist; Jeremy G Thompson; Darryl L Russell
Journal:  Reproduction       Date:  2016-11-22       Impact factor: 3.906

5.  A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer.

Authors:  Paul Devroey; Antonio Pellicer; Anders Nyboe Andersen; Joan-Carles Arce
Journal:  Fertil Steril       Date:  2012-01-13       Impact factor: 7.329

Review 6.  Oocyte maturation failure: a syndrome of bad eggs.

Authors:  Stephanie Beall; Carol Brenner; James Segars
Journal:  Fertil Steril       Date:  2010-04-07       Impact factor: 7.329

7.  Factors inducing decreased oocyte maturation rate: a retrospective analysis of 20,939 ICSI cycles.

Authors:  Yihua Lin; Puyu Yang; Yanrong Chen; Jinliang Zhu; Xinyu Zhang; Caihong Ma
Journal:  Arch Gynecol Obstet       Date:  2019-01-04       Impact factor: 2.344

Review 8.  Maturation of Oocytes in Vitro.

Authors:  Patrick Lonergan; Trudee Fair
Journal:  Annu Rev Anim Biosci       Date:  2015-11-09       Impact factor: 8.923

9.  Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection.

Authors:  Craig A Witz; Gaurang S Daftary; Kevin J Doody; John K Park; Yodit Seifu; Vladimir I Yankov; Patrick W Heiser
Journal:  Fertil Steril       Date:  2020-05-13       Impact factor: 7.329

10.  The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropin.

Authors:  Joan-Carles Arce; Bjarke M Klein; Antonio La Marca
Journal:  Gynecol Endocrinol       Date:  2014-02-27       Impact factor: 2.260

  10 in total
  1 in total

1.  Which ovarian stimulation parameters influence the number and proportion of mature oocytes retrieved in IVF cycles?

Authors:  Ankita Sethi; Neeta Singh; Garima Patel
Journal:  J Assist Reprod Genet       Date:  2021-10-08       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.